Visicell granted NSF SBIR Phase I award

VisiCELL Medical Inc. is delighted to receive the National Science Foundation (NSF) SBIR Phase I grant award to further develop and extend our product offerings for non-invasive clinical imaging of cell therapy products in the subjects, a critical unmet medical need the cell therapy developers and the clinical investors are experiencing during their product development. Our goal is to help accelerate the product development and reduce time to market for the benefits of the patients with these transformative and potentially curative cell-based therapy. Let's do this

-Visicell Medical Team